DOW JONES · 2026-10-22 02:58 UTC

Arcus Biosciences: Granted Underwriters 30-Day Option to Purchase Up to 2.1M Additional Shares of Its Common Stock at Public Offering Price >RCUS

Loading the story on Tree News…